Monitor for additional insider selling or commentary around clinical trial progress; current activity is routine and not materially concerning given the small size relative to market cap.
Price Chart
Executive Summary
A single insider sale occurred at Stoke Therapeutics, with Director Arthur A. Levin selling 605 shares for $22,264 in the past week. This transaction is part of a broader pattern of recent insider selling, with four sales totaling $1.8 million over the last 30 days. The activity represents minimal economic impact relative to the company's $1.9B market cap.
Key Financial Metrics
Key Facts
- Director Arthur A. Levin sold 605 shares at $36.80 per share for a total of $22,264
- Transaction was an open-market sale (Form 4 code 'S')
- Part of a cluster of 4 insider sales totaling $1.8M over the past 30 days
- Total recent insider selling ($1.8M) represents only 0.09% of the company's $1.9B market cap
Financial Impact
$22,264 in open-market sales by one director; $1.8M total insider sales over 30 days
Risk Factors
- Continued insider selling could signal waning confidence
- Biotech valuation sensitivity to clinical trial outcomes not reflected in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (1 trades, 7d window) | cluster-STOK-1773782609580 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $33.03 $28.93 | ▼ −12.41% | ▼ −10.46% | $25.91 (−21.56%) |
Aug 3, 2026 8w ago | 8-K | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Aug 3, 2026 8w ago | 424B5 | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Jun 30, 2026 13w ago | 8-K | $32.72 $29.31 | ▼ −10.42% | ▼ −9.39% | $25.91 (−20.82%) |
May 7, 2026 21w ago | 8-K | $32.89 $30.01 | ▼ −8.76% | ▼ −8.78% | $25.91 (−21.23%) |
Apr 22, 2026 23w ago | DEFA14A | $34.93 $30.30 | ▼ −13.27% | ▼ −17.90% | $25.91 (−25.83%) |
Apr 7, 2026 25w ago | 8-K | $34.87 $32.96 | ▼ −5.48% | ▼ −14.02% | $25.91 (−25.70%) |
Mar 13, 2026 29w ago | Insider Cluster | $33.19 $35.05 | ▼ −5.60% | ▼ −2.02% | $25.91 (+21.94%) |
Mar 10, 2026 29w ago | Insider Cluster | $38.35 $34.87 | ▼ −9.07% | ▼ −8.92% | $25.91 (−32.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access